Compare Aurora Cannabis Inc (ACB) vs Opendoor Technologies Inc (OPEN) Price & Performance

Aurora Cannabis (ACB) trades at $2.71, down 4.58% on the day, with a bearish technical outlook. The company reported a net income of $1.59 million in 2025, a significant improvement from a $69 million loss in 2024, though 2026 guidance projects a net loss of $136 million. Revenue grew to $343.29 million in 2025, but faces headwinds from Canadian reimbursement pressures. Analyst consensus is mixed, with 21.43% buy, 57.14% hold, and 21.43% sell ratings.

The stock's low P/B of 0.47 suggests undervaluation, but negative profitability metrics and a projected reset year in 2027 pose risks. Investment appeal hinges on execution in high-margin international medical markets, though volatility and competitive pressures remain key concerns for shareholders.

Opendoor Technologies (OPEN) trades at $4.79, down 2.24% on the day, with a bullish technical signal from moving averages but mixed oscillators. The company reported a net loss of $1.30 billion on $4.37 billion revenue in 2025, with a negative net income margin of -35.25%. Recent news highlights a new CEO, a shift to the Opendoor 2.0 model, and the closure of India operations to focus on AI-driven efficiencies.

The outlook remains challenging with persistent losses and a highly leveraged balance sheet, though cost discipline and AI integration offer potential for margin improvement. Key risks include housing market volatility and high debt levels. Analyst consensus is cautious with 65.39% hold ratings, reflecting uncertainty around the path to profitability.